Earnings Feed
Start Free
MediWound Ltd.·4

Jun 4, 4:05 PM ET

SHAMIR NACHUM 4

4 · MediWound Ltd. · Filed Jun 4, 2026

Research Summary

AI-generated summary of this filing

Updated

MediWound (MDWD) Director Shamir Nachum Buys 6,000 Shares

What Happened

  • Shamir Nachum, a director of MediWound Ltd. (MDWD), made two open-market purchases on 2026-06-03 totaling 6,000 ordinary shares. He bought 175 shares at $13.97 (reported value $2,446) and 5,825 shares at $14.00 (reported value $81,550), for a combined reported value of $83,996. This was a purchase transaction (often viewed positively by investors, though it does not prove future performance).

Key Details

  • Transaction dates and prices:
    • 2026-06-03 — 175 shares @ $13.97 (reported $2,446)
    • 2026-06-03 — 5,825 shares @ $14.00 (reported $81,550)
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Notable footnotes:
    • F1: Some reported ordinary shares consist of RSUs granted Mar 4, 2026 that vest 100% on the one‑year anniversary.
    • F2: Certain rows were informational; no transactions were effected for those securities.
    • F3: Options reported were granted Mar 4, 2026 and vest 100% on the one‑year anniversary.
  • Timeliness: Filing was made 2026-06-04 for transactions on 2026-06-03 (filed the next day), so no late-filing indication in the provided data.
  • Other: Exhibit 24.1 (Power of Attorney) included in the filing.

Context

  • The filing shows open-market purchases, not option exercises or immediate sales. The footnotes indicate separate RSU and option grants from March 4, 2026 that vest in one year; those are grants/holdings information rather than the June 3 purchases. Purchases by insiders can be of interest to retail investors as one data point, but they do not guarantee company performance.

Insider Transaction Report

Form 4
Period: 2026-06-03
MediWound Ltd.MDWD
SHAMIR NACHUM
Director
Transactions
  • Purchase

    Ordinary Shares

    2026-06-03$13.97/sh+175$2,446→ 49,990 total
  • Purchase

    Ordinary Shares

    2026-06-03$14.00/sh+5,825$81,550→ 55,815 total
Holdings

  • Ordinary shares

    [F1][F2]
    1,200

  • Series A Warrants

    Exercise: $13.47From: 2022-11-28Exp: 2026-11-28→ Ordinary Shares (16,336 underlying)
    16,336

  • Stock Option (right to buy ordinary shares)

    [F2]
    Exercise: $12.49From: 2023-08-17Exp: 2032-08-17→ Ordinary Shares (28,571 underlying)
    28,571

  • Stock Option (right to buy ordinary shares)

    [F2]
    Exercise: $11.88From: 2024-05-31Exp: 2033-05-30→ Ordinary Shares (11,800 underlying)
    11,800

  • Stock Option (right to buy ordinary shares)

    [F2]
    Exercise: $12.73From: 2025-02-26Exp: 2034-02-26→ Ordinary Shares (12,570 underlying)
    12,570

  • Stock Option (right to buy ordinary shares)

    [F2]
    Exercise: $18.54From: 2026-02-11Exp: 2035-02-11→ Ordinary Shares (9,200 underlying)
    9,200

  • Stock Option (right to buy ordinary shares)

    [F2][F3]
    Exercise: $17.60Exp: 2036-03-04→ Ordinary Shares (10,000 underlying)
    10,000
Footnotes (3)
  • [F1]The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
  • [F2]There were no transactions affected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
  • [F3]The options reported in this row were granted to the Reporting Person on March 4, 2026 and vest 100% on the one-year anniversary of the grant date.
Signature
/s/ Yaron Meyer, attorney-in-fact|2026-06-04

Documents

2 files